A wave of under-the-radar HIV policy changes is unfolding nationwide, with advocates warning of serious, far-reaching consequences.

A Q&A With Shauna Applin, ARNP. AJMC: Despite substantial therapeutic advances since the 1980s, the US is not on pace to achieve the goals of the Ending the HIV Epidemic (EHE) public health initiative ...

For millions of people living with HIV, a daily regimen of medications is a lifelong necessity. If they stop taking the drugs ...

Three experimental injectable antiretrovirals – a novel capsid inhibitor and two next-generation integrase inhibitors – could ...

What are the three types of HIV tests available to patients, how do they differ, and how can patients determine the best ...

A new study published in The Lancet Microbe reports the first twice-yearly injectable HIV treatment regimen—combining lenacapavir, teropavimab, and zinlirvimab—has achieved high rates of viral ...

Since the HIV epidemic began, the diagnosis of HIV has evolved from a death sentence to a chronic, but manageable condition by starting and staying on treatment. HIV treatment can help people live ...

A dual-action HIV antibody–drug conjugate forces Env to open, then blocks it, boosting virus neutralization up to tenfold in the lab.

Women living with HIV/AIDS can now have safe and healthy pregnancies with early diagnosis, proper treatment, and consistent ...

Thousands of low-income Americans with HIV are losing access to vital medications, as states grapple with a lack of federal ...

Harerimana Ismail of Uganda is a community health worker who checks on kids with HIV. He lost his salary after the Trump ...